Atherosclerosis imaging with 18F-sodium fluoride PET: state-of-the-art review
Open Access
- 27 November 2019
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (6) , 1538-1551
Abstract
Purpose: We examined the literature to elucidate the role of 18F-sodium fluoride (NaF)-PET in atherosclerosis.Methods: Following a systematic search of PubMed/MEDLINE, Embase, and Cochrane Library included articles underwent subjective quality assessment with categories low, medium, and high. Of 2811 records, 1780 remained after removal of duplicates. Screening by title and abstract left 41 potentially eligible full-text articles, of which 8 (about the aortic valve (n= 1), PET/MRI feasibility (n= 1), aortic aneurysms (n= 1), or quantification methodology (n= 5)) were dismissed, leaving 33 published 2010–2012 (n= 6), 2013–2015 (n= 11), and 2016–2018 (n= 16) for analysis.Results: They focused on coronary (n= 8), carotid (n= 7), and femoral arteries (n= 1), thoracic aorta (n= 1), and infrarenal aorta (n= 1). The remaining 15 studies examined more than one arterial segment. The literature was heterogeneous: few studies were designed to investigate atherosclerosis, 13 were retrospective, 9 applied both FDG and NaF as tracers, 24 NaF only. Subjective quality was low in one, medium in 13, and high in 19 studies. The literature indicates that NaF is a very specific tracer that mimics active arterial wall microcalcification, which is positively associated with cardiovascular risk. Arterial NaF uptake often presents before CT-calcification, tends to decrease with increasing density of CT-calcification, and appears, rather than FDG-avid foci, to progress to CT-calcification. It is mainly surface localized, increases with age with a wide scatter but without an obvious sex difference. NaF-avid microcalcification can occur in fatty streaks, but the degree of progression to CT-calcification is unknown. It remains unknown whether medical therapy influences microcalcification. The literature held no therapeutic or randomized controlled trials.Conclusion: The literature was heterogeneous and with few clear cut messages. NaF-PET is a new approach to detect and quantify microcalcification in early-stage atherosclerosis. NaF uptake correlates with cardiovascular risk factors and appears to be a good measure of the body’s atherosclerotic burden, potentially suited also for assessment of anti-atherosclerotic therapy.Keywords
This publication has 65 references indexed in Scilit:
- Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteriesProceedings of the National Academy of Sciences, 2013
- Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcificationRevista Española de Medicina Nuclear e Imagen Molecular, 2013
- Coronary Arterial 18F-Sodium Fluoride UptakeJACC, 2012
- Association of vascular fluoride uptake with vascular calcification and coronary artery diseaseNuclear Medicine Communications, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Correlation of Inflammation Assessed by 18F-FDG PET, Active Mineral Deposition Assessed by 18F-Fluoride PET, and Vascular Calcification in Atherosclerotic Plaque: A Dual-Tracer PET/CT StudyJournal of Nuclear Medicine, 2011
- In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk FactorsJournal of Nuclear Medicine, 2011
- 18F-FDG Uptake and Calcifications in the Thoracic Aorta on Positron Emission Tomography/Computed Tomography ExaminationsJournal of Thoracic Imaging, 2011
- Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic PlaqueJournal of Nuclear Medicine, 2010
- 18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factorsSeminars in Nuclear Medicine, 2002